The Centers for Disease Control – NCEH is seeking applications to increase the capacity and capability of state and territorial newborn screening laboratories to test for newborn screening conditions as recommended by the U.S. Department of Health and Human Services (HHS) Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC), and those that might be added to individual state panels by state-level advisory committees or state legislatures.
Donor Name: Centers for Disease Control – NCEH
State: All States
County: All Counties
U.S. Territories: Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau
Type of Grant: Grant
Deadline (mm/dd/yyyy): 05/09/2022
Grant Size: $375,000
Grant Duration: 2 years
Details:
Early detection of these conditions, whose symptoms are not clinically observable at birth, save thousands of infants and children from disability and death through early detection and treatment. With this 2-year funding opportunity, CDC intends to support up to 8 state or territorial newborn screening laboratories to add HHS ACHDNC-recommended newborn screening conditions to their newborn screening panel. CDC intends to work collaboratively with recipients to enhance state and territorial newborn screening laboratory capability to implement these and future HHS ACHDNC -recommended newborn screening conditions. CDC also intends to work collaboratively with recipients to improve the quality of newborn screening testing in the U.S., in part through data harmonization efforts. This funding will result in a greater number of newborns that are appropriately screened, identified, and referred for treatment for condition detected through state newborn dried blood spot screening.
Advanced biochemical and molecular technologies improve disease detection for newborns, and newborn screening programs must provide accurate interpretation of complex biomarker profiles, develop analytic and interpretive tools for genetic testing, and manage complex data systems. Moreover, there is a need for harmonization of results across laboratories and testing platforms to aid in biomarker interpretation. Harmonization occurs when data across different formats and naming conventions are combined and transformed them into a cohesive data set.
Funding Information
- Total Period of Performance Funding: $8,000,000
- Average One Year Award Amount: $375,000
- Total Period of Performance Length: 2 years
Applicant entities to whom this provision applies include state, local, territorial governments (including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau), or their bona fide agents, political subdivisions of states (in consultation with states), federally recognized or state-recognized American Indian or Alaska Native tribal governments, and American Indian or Alaska Native tribally designated organizations.
For more information, visit Grants.gov.
